HealthStream, Inc.
HSTM Healthcare Health Information Services
HealthStream, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $304.1 million, up 4.26% from fiscal 2024. In the quarter to June 2026, revenue grew 12.6%, EPS grew 27.8% and free cash flow grew 362.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for five.
Follow HSTM
HealthStream, Inc. (HSTM) EV/Sales
As of 16 October 2026, HealthStream, Inc. (HSTM) trades at a EV/Sales of 2.9×. Over the past ten years it has ranged from 1.7× (April 2026) to 4.7× (June 2015); the current reading is higher than 51% of that period. That is above the Health Information Services industry median of 2.6× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 2.2× | (29.06%) |
| FY2024 | 3.1× | 11.02% |
| FY2023 | 2.8× | 1.24% |
| FY2022 | 2.7× | (12.98%) |
| FY2021 | 3.1× | 13.30% |
| FY2020 | 2.8× | (4.13%) |
| FY2019 | 2.9× | 5.04% |
| FY2018 | 2.8× | (8.53%) |
| FY2017 | 3.0× | (21.30%) |
| FY2016 | 3.8× | 48.12% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 2.4× | 29.11% |
| Mar 2026 | 1.8× | (16.24%) |
| Dec 2025 | 2.2× | (15.80%) |
| Sep 2025 | 2.6× | (1.46%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| MDRX Veradigm Inc. compare | 0.6× |
| TDOC Teladoc Health, Inc. compare | 0.9× |
| OMCL Omnicell, Inc. compare | 1.3× |
| PHR Phreesia, Inc. compare | 1.5× |
| GDRX GoodRx Holdings, Inc. compare | 1.7× |
| OMDA Omada Health, Inc. compare | 2.8× |
| HSTM HealthStream, Inc. | 2.9× |
| CERT Certara, Inc. compare | 3.7× |
| SOPH SOPHiA GENETICS SA compare | 5.1× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)